Recruiting

Digital Contingency Management

Sponsor:

University of Michigan

Code:

NCT07178990

Conditions

Opioid Agonist Treatment

Alcohol Use Disorder

Opioid Use Disorder

Eligibility Criteria

Sex: All

Age: 19 - 63

Healthy Volunteers: Not accepted

Interventions

Digital Contingency Management Intervention Arm

Digital Wellness Arm

Study Details

Brief summary:

This pilot study addresses the urgent public health crisis of co-occurring opioid and alcohol use disorders (OUD-AUD), leading causes of mortality in the United States, by testing a scalable digital contingency management (CM) treatment among Medicaid beneficiaries. The study aims to evaluate the feasibility and acceptability of digital CM for OUD-AUD recovery, while also planning for broader implementation.

Conditions

Opioid Agonist Treatment

Alcohol Use Disorder

Opioid Use Disorder

Study ID

NCT07178990

Start date

Dec 8, 2025

Status verified date

Dec, 2025

Completion date

Jul 31, 2027

Anticipated

Primary completion date

Jul 1, 2027

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 19 - 63

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • Participants must be enrolled in the Michigan Medicaid program
  • Opioid agonist treatment (OAT): Participants must have initiated OAT with buprenorphine or methadone
  • Participants must have an OAT prescription and Alcohol use disorder (AUD) based on self-report measure during screening
  • Participants must have regular access to a working smartphone and internet connection.
  • Participants must have a reliable mailing address to receive study supplies (e.g., salivary drug tests).

Exclusion Criteria:

  • Primary Medicare Coverage: Individuals that are dual-eligible for Medicaid and Medicare and aged 65 or older, due to limited availability of Medicaid claims data for this group
  • Individuals that cannot voluntarily provide informed consent themselves for any reason, including legal incompetency
  • Individuals with substantial cognitive impairment that would interfere with study participation
  • Individuals unable to read or understand English
  • Individuals experiencing active suicidality or psychosis.
  • Individuals with a planned admission to residential treatment or incarceration during the study period.

Study Design

Enrollment

50 participants

Anticipated

Allocation

Randomized

Intervention Model

Parallel Assignment

Primary purpose

Treatment

Interventions and Outcome Measures

Arms

experimental: Digital Contingency Management (CM) Intervention Arm

After participants meet eligibility and complete the DynamiCare assessment period, participants randomized to this group will receive a comprehensive digital CM platform designed to enhance OAT retention and promote abstinence from alcohol and opioids. This will include the DynamiCare Motivation Support Program.

active comparator: Wellness Condition

After participants meet eligibility and complete the DynamiCare assessment period, those randomized to this group will receive a wellness digital platform that includes surveys, testing, and tech support.

Interventions

Digital Contingency Management Intervention Arm

Participants will use a version of the app for 6-months. Participants in this group may earn rewards for completing recovery-related activities and for abstinence from drugs and alcohol. During the 6 months this will include: random saliva drug tests, breathalyzer tests, and video selfies, completing surveys and questionnaires through the app, and receiving rewards on a debit card for abstinent tests, surveys, and activities. Additionally, participants will complete follow-up at approximately 9 months after randomization.

Digital Wellness Arm

Participants will use a version of the app for 6-months focussed on wellness. During the 6 months this will include: random requests to do saliva drug tests, breathalyzer tests, and video selfies, complete surveys and questionnaires through the app, and receive rewards on a debit card for completing tests, surveys, and activities. Participants in this group may also earn rewards for completing study activities like tests and surveys. Additionally, participants will complete follow-up at approximately 9 months after randomization.

Primary outcome measure

  • Feasibility based on recruitment [ Time Frame: Recruitment period 12 months ]
  • Feasibility based on adherence [ Time Frame: 6 months (during the Dynamicare program) ]
  • Feasibility based on Retention [ Time Frame: 6 months ]
  • Acceptability of the intervention [ Time Frame: 3-month after starting program ]

Central Contacts and Locations

Central contacts

Haley Stevens

734-764-9910hsteve@med.umich.edu

Locations

University of Michigan

Recruiting

Ann Arbor, Michigan, United States, 48109

Contacts

Haley Stevens

734-764-9910hsteve@umich.edu

Principal Investigator:

Anne Fernandez, PhD

More Information

Sponsor

University of Michigan

Last update posted

Aug 6, 2026

Last verified

Dec, 2025

Keywords

  • Research surveys
  • App based program
  • Smartphone

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by University of Michigan on 2026-08-06.